$RVT

Royce Small-Cap Trust, Inc. (NYSE-RVT) declares Third Quarter Common Stock Distribution of $0.29 Per Share - Royce Value Trust (NYSE:RVT)

NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Royce Small-Cap Trust, Inc. ( NYSE-RVT ) has declared a quarterly distribution of $0.29 per share on its Common Stock.

Original reporting
Benzinga · PRNewswire
Published Sep 3, 2025, 2:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RVT
Bullish
high confidence
Mentioned
$RVT
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$RVTBullishMed
01

Why it matters

The recent distribution announcement reinforces the trust's income-generating profile, which could attract income-seeking investors and support the stock price.

02

Market read

The news is highly relevant for income-focused investors and traders monitoring small-cap trusts, with immediate implications for RVT's stock performance.

03

What to watch

Potential tax implications of dividend income and changes in interest rates could influence investor sentiment and stock performance.

Timing: High, as the distribution was announced on September 3, 2025, and is scheduled for the upcoming quarter.

Background

Royce Small-Cap Trust, Inc. is a closed-end fund focusing on small-cap stocks, providing income through regular distributions.

Company-level read

Ticker impact

$RVTBullishHigh confidence
Context

The news pertains directly to Royce Value Trust (RVT), which is relevant for investors and traders focusing on this specific trust.

Expected impact

Moderate upward price movement expected in the short term, approximately 1-2% increase within the next week.

Evidence & confidence

Regular dividend declarations often signal stable income streams and management confidence, which can attract income-focused investors.

Market effects

The distribution announcement may reinforce investor confidence in the financial markets sector, especially in income-generating trusts.

Limited regional impact, primarily affecting US-based investors and markets.

Negligible, as the news pertains to a specific US trust.

Counterpoint

The distribution may be priced in already, and the stock could experience a short-term correction if broader market conditions deteriorate.

Key entities

  • Royce Small-Cap Trust, Inc.

    A closed-end fund investing in small-cap stocks.

Related articles

$GISMed

General Mills Announces Dana McNabb As CEO

General Mills' board elected Dana McNabb, current COO, as CEO effective January 2027, succeeding Jeff Harmening, who will become executive chair. McNabb, with 27 years at the company, has led key operating segments and functions. She aims to drive profitable growth through digital demand and supply chain modernization, building on Harmening's foundation.

$GISMed

General Mills Names First Woman CEO

General Mills has named Dana McNabb as its next CEO, the first woman to lead the company. McNabb, currently COO, will take over on January 1. Current CEO Jeff Harmening will become executive chairman. The board unanimously approved the change.

$HPEMedAI 8/10

HPE Networking chief links $1.2B Vultr neocloud win to ‘revenue synergy’ opportunity

Hewlett Packard Enterprise (HPE) secured a $1.2B deal with Vultr for its AMD Helios AI Rack system, highlighting revenue synergy opportunities. The deal involves deploying HPE's AI Rack in Vultr's U.S. data centers to support AI workloads. HPE's executive Rami Rahim stated this opens a new networking market, with Helios representing a billion-dollar opportunity over two years, and networking tray orders already exceeding $200M.

$LLYMedAI 8/10

Retatrutide Yields Significant Weight Loss in T2D

Eli Lilly's phase 3 TRIUMPH-2 study shows retatrutide, a triple hormonal agonist, achieved significant weight loss (up to 20.8%) and glycemic improvements in adults with type 2 diabetes (T2D) and obesity. The study, presented at EASD 2026, involved 1152 participants and showed retatrutide's efficacy estimand exceeded 20% weight reduction, a threshold not previously reached in T2D patients.

$BAMMedAI 9/10

U.S. – Korea Framework Advances Deployment of Westinghouse Nuclear Technology in the United States

The U.S. and Korea agreed on a framework committing up to $120B in Korean investment for constructing eight nuclear reactors in the U.S., including six Westinghouse AP1000 reactors and two Korean APR1400 reactors. The deal includes a 5-10% equity investment in Westinghouse by Korea. Brookfield Asset Management and Cameco are partners in the project, which aims to expand U.S. nuclear capacity to meet growing energy demand.